Sponsor or institution
Clinical trials and research at GeneCradle Inc
As of November 12, 2026, Find a Trial lists 5 clinical trials run by GeneCradle Inc that are recruiting, in China. By phase: Phase 1/2 (3), Phase 3 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Gene therapy for treating Type 2 Spinal Muscular Atrophy | Phase 3 | Beijing and 6 other locations | Recruiting | May 14, 2025 |
| Gene therapy for treating spinal muscular atrophy type 3 | Phase 1/2 | Beijing, Beijing Municipality | Recruiting | May 20, 2024 |
| Gene therapy for late-onset Pompe disease | Phase 1/2 | Beijing | Recruiting | Apr 30, 2024 |
| Evaluating a gene therapy drug for patients with high triglycerides and pancreatitis | Phase 1 | Beijing, Beijing Municipality | Recruiting | May 16, 2023 |
| Gene therapy for treating spinal muscular atrophy Type 1 | Phase 1/2 | Beijing and 3 other locations | Recruiting | Apr 21, 2023 |
All recruiting trials (5)
-
Gene therapy for treating Type 2 Spinal Muscular Atrophy
This study is testing a new gene therapy called GC101 to see if it can help children aged 2 to 12 with Type 2 Spinal Muscular Atrophy feel better compared to their current treatment.
-
Gene therapy for treating spinal muscular atrophy type 3
This study is testing a new gene therapy for people with spinal muscular atrophy type 3 to see if it is safe and helps improve their movement over time.
-
Gene therapy for late-onset Pompe disease
This study is testing a new gene therapy called GC301 to see if it can improve breathing and overall health in kids and adults with late-onset Pompe disease.
-
Evaluating a gene therapy drug for patients with high triglycerides and pancreatitis
This study is testing a new gene therapy drug to see if it can help people with high triglycerides and a history of pancreatitis feel better when other treatments haven't worked.
-
Gene therapy for treating spinal muscular atrophy Type 1
This study is testing a new gene therapy for babies with spinal muscular atrophy Type 1 to see if it helps them sit up on their own by 18 months old.
Quick answers
How many clinical trials run by GeneCradle Inc are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 3, Phase 3: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.